Abstract
In vivo prostate-specific membrane antigen (PSMA) overexpression creates an opportunity for PSMA-directed theranostic approach in adenoid cystic carcinoma of the parotid. Herein, we illustrate a patient with metastatic PSMA-directed theranostic approach in adenoid cystic carcinoma of the parotid who had intense PSMA uptake on metastatic lesions, followed by radionuclide therapy with Lu-PSMA.
MeSH terms
-
Carcinoma, Adenoid Cystic / metabolism
-
Carcinoma, Adenoid Cystic / pathology*
-
Carcinoma, Adenoid Cystic / radiotherapy*
-
Female
-
Glutamate Carboxypeptidase II / therapeutic use*
-
Humans
-
Lutetium / therapeutic use*
-
Middle Aged
-
Neoplasm Metastasis
-
Parotid Neoplasms / metabolism
-
Parotid Neoplasms / pathology*
-
Parotid Neoplasms / radiotherapy*
-
Radioisotopes / therapeutic use*
Substances
-
Radioisotopes
-
Lutetium
-
Lutetium-177
-
Glutamate Carboxypeptidase II